Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
dyslipidemia
Special Reports
2020’s top 10 clinical trial flops
While big companies can shrug off a failure, smaller companies may see their entire futures be placed in jeopardy.
Phil Taylor
Jan 25, 2021 3:00am
Novo bags €430M Staten buyout option
Dec 17, 2018 8:58am
Gemphire cuts 33% of staff, including CFO, CMO
Sep 25, 2018 10:10am
Gemphire’s CEO resigns for ‘personal reasons'
May 31, 2017 4:31am
Ionis spinout Akcea files for $100M IPO
Mar 27, 2017 7:50am
EuroBiotech—More Articles of Note
Mar 9, 2017 9:42am